Joan Massagué

Joan Massagué (born April 30, 1953), is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Joan Massagué', query time: 0.02s Refine Results
  1. 1
    The transcription factor Rreb1 regulates epithelial architecture, invasiveness, and vasculogenesis in early mouse embryos

    The transcription factor Rreb1 regulates epithelial architecture, invasiveness, and vasculogenesis in early mouse embryos by Sophie M Morgani, Jie Su, Jennifer Nichols, Joan Massagué, Anna-Katerina Hadjantonakis

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer

    Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer by Sakari Vanharanta, Christina B Marney, Weiping Shu, Manuel Valiente, Yilong Zou, Aldo Mele, Robert B Darnell, Joan Massagué

    Published 2014-06-01
    Get full text
    Article
  3. 3
    Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization

    Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization by Harihar Basnet, Lin Tian, Karuna Ganesh, Yun-Han Huang, Danilo G Macalinao, Edi Brogi, Lydia WS Finley, Joan Massagué

    Published 2019-03-01
    Get full text
    Article
  4. 4
    Molecular basis for DNA recognition by the maternal pioneer transcription factor FoxH1

    Molecular basis for DNA recognition by the maternal pioneer transcription factor FoxH1 by Radoslaw Pluta, Eric Aragón, Nicholas A. Prescott, Lidia Ruiz, Rebeca A. Mees, Blazej Baginski, Julia R. Flood, Pau Martin-Malpartida, Joan Massagué, Yael David, Maria J. Macias

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas

    Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas by Paul K. Paik, Jia Luo, Ni Ai, Rachel Kim, Linda Ahn, Anup Biswas, Courtney Coker, Wanchao Ma, Phillip Wong, Darren J. Buonocore, W. Victoria Lai, Jamie E. Chaft, Swarnali Acharyya, Joan Massagué, Mark G. Kris

    Published 2022-10-01
    Get full text
    Article
  6. 6
    Anti-tumor effects of an ID antagonist with no observed acquired resistance

    Anti-tumor effects of an ID antagonist with no observed acquired resistance by Paulina M. Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang, Bina Desai, Yvette Chin, Riddhi Shah, Sijia Xu, Saurabh Yadav, Sergey Yaklichkin, Ouathek Ouerfelli, Rajesh Kumar Soni, John Philip, David C. Montrose, John H. Healey, Vinagolu K. Rajasekhar, William A. Garland, Jeremy Ratiu, Yuan Zhuang, Larry Norton, Neal Rosen, Ronald C. Hendrickson, Xi Kathy Zhou, Antonio Iavarone, Joan Massague, Andrew J. Dannenberg, Anna Lasorella, Robert Benezra

    Published 2021-05-01
    Get full text
    Article

Search Tools: